Is The Government Letting Big Pharma Slide On Off-Label Promotion?
More than 200 families have now filed lawsuits against GlaxoSmithKline, claiming the company deceived physicians and patients into using the anti-nausea drug Zofran, a prescription approved... Read More
First Amendment Protects “Truthful, Non-Misleading” Off Label Promotion, NY Judge Rules
When Kim Kardashian West publishes photos on Instagram, she probably doesn’t expect a response from the US Food & Drug Administration. But that’s just what the reality... Read More
Reporting Birth Defects Associated With Zofran To The FDA
The US Food & Drug Administration maintains a vast database of Adverse Event Reports, or AERs. AERs describe unfavorable health outcomes that physicians and other... Read More
Zofran Has Now Been Linked To Major Birth Defects. Have GlaxoSmithKline & The FDA Responded?
Since its approval in 1991, the anti-nausea drug Zofran has undergone several major labeling revisions. For a pharmaceutical product, this isn’t uncommon. When a drug... Read More
How Big Pharma Controls Drug Research
In our last article, we covered the numerous methods pharmaceutical manufacturers employ to buy the support of health care professionals, doctors and teaching hospitals. Drug... Read More
Pay To Promote: The Pharmaceutical Industry’s Financial Relationships With Doctors
In our last article, we discussed a series of charges filed by the US Department of Justice against the international pharmaceutical giant GlaxoSmithKline. We focused... Read More
